Avatrombopag (Sucoxin) manufacturers and product comparisons of different versions

Avatrombopag (Avatrombopag) is an oral thrombopoietin receptor agonist (TPO-RA), mainly used to treat chronic liver disease-related thrombocytopenia and immune thrombocytopenia. The drug was originally developed by Dova Pharmaceuticals in the United States, and is produced and sold by AbbVie. The product quality complies with international GMP standards, ensuring the reliability of the drug in research and development, production and supply chain.

In the domestic market, the imported original drug of avatrombopag has been launched and included in medical insurance, and is available in two specifications: 20mg10 tablets and 20mg15 tablets. The latest price of 20mg10 tablets is around 5,000 yuan, and 20mg15 tablets is about 7,000 to 8,000 yuan. The specific medical insurance reimbursement amount needs to be determined according to the local hospital pharmacy policy. The ingredients and efficacy of imported original drugs are consistent with international original standards, providing patients with stable and reliable treatment options.

In addition, domestically produced generic drugs have been launched in China, with a price of more than 3,000 yuan. Compared with imported original drugs, the economic burden is lower. At the same time, the drug ingredients are basically the same as the original drugs, providing patients with more treatment options. In overseas markets, there are also Lao and Bangladeshi generic drugs, which cost only a few hundred yuan. Their efficacy is the same as that of the original drug, and they are suitable for patients undergoing long-term maintenance treatment.

Overall, there are many options for avatrombopag in the domestic and international markets. Patients can make reasonable choices between imported original drugs, domestic generic drugs or overseas generic drugs based on economic conditions, medical insurance policies and doctor's recommendations. During use, it is necessary to strictly follow the doctor's instructions and regularly monitor platelet levels to ensure efficacy and medication safety.

Reference materials:https://www.drugs.com/